FORMULA GROWTH LTD - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
FORMULA GROWTH LTD ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2022$334,000
-58.7%
20,034
-63.5%
0.10%
-57.6%
Q2 2022$809,000
-40.6%
54,9510.0%0.22%
-12.8%
Q1 2022$1,363,000
-27.6%
54,951
-6.3%
0.26%
-23.1%
Q4 2021$1,882,000
-12.8%
58,674
-2.2%
0.33%
+8.1%
Q3 2021$2,159,00060,0000.31%
Other shareholders
PULMONX CORP shareholders Q4 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders